Does CARVEDILOL Cause Peripheral arterial occlusive disease? 18 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Peripheral arterial occlusive disease have been filed in association with CARVEDILOL (Carvedilol Phosphate). This represents 0.1% of all adverse event reports for CARVEDILOL.
18
Reports of Peripheral arterial occlusive disease with CARVEDILOL
0.1%
of all CARVEDILOL reports
0
Deaths
12
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From CARVEDILOL?
Of the 18 reports, 12 (66.7%) required hospitalization.
Is Peripheral arterial occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARVEDILOL. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does CARVEDILOL Cause?
Hypotension (1,822)
Dyspnoea (1,143)
Dizziness (1,138)
Drug ineffective (1,102)
Fatigue (1,020)
Completed suicide (1,019)
Bradycardia (861)
Toxicity to various agents (690)
Cardiac failure (636)
Asthenia (562)
What Other Drugs Cause Peripheral arterial occlusive disease?
NILOTINIB (319)
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
IMATINIB (86)
ASPIRIN (77)
ATORVASTATIN (70)
METOPROLOL (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)
Which CARVEDILOL Alternatives Have Lower Peripheral arterial occlusive disease Risk?
CARVEDILOL vs CASIMERSEN
CARVEDILOL vs CASIRIVIMAB
CARVEDILOL vs CASIRIVIMAB\IMDEVIMAB
CARVEDILOL vs CASPOFUNGIN
CARVEDILOL vs CATEQUENTINIB